CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $30.24M, above the global median of $18.73M
- FinancialsAltman Z-Score 5.97: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.81BCNY569.18M · vs all stocks (USD)
Revenue (TTM)
654.72MCNY97.70M · vs all stocks (USD)
Profit Margin
-1.54%vs Diagnostics & Research peers
Beta
0.4260xvs all stocks
52-Week Change
3.87%vs all stocks
Market Capitalization
3.81BCNY569.18M · vs all stocks (USD)
Enterprise Value
2.82BCNY421.24M · vs all stocks (USD)
Forward P/E
21.85xvs Diagnostics & Research peers
Price to Sales (TTM)
5.83xvs Diagnostics & Research peers
Price to Book (MRQ)
0.9725xvs Diagnostics & Research peers
Enterprise to Revenue
4.31xvs Diagnostics & Research peers
Enterprise to EBITDA
29.84xvs Diagnostics & Research peers
Gross Margin
50.00%vs Diagnostics & Research peers
Profit Margin
-1.54%vs Diagnostics & Research peers
Operating Margin
11.08%vs Diagnostics & Research peers
Return on Assets (TTM)
-0.83%vs Diagnostics & Research peers
Return on Equity (TTM)
-0.53%vs Diagnostics & Research peers
Revenue (TTM)
654.72MCNY97.70M · vs all stocks (USD)
Revenue per Share (TTM)
1.04CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-3.70%vs Diagnostics & Research peers
Gross Profit (TTM)
287.55MCNY42.91M · vs all stocks (USD)
EBITDA (TTM)
50.15MCNY7.48M · vs all stocks (USD)
Net Income (TTM)
-10.09MCNY-1.51M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
29.96%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
356.92MCNY53.26M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
202.63MCNY30.24M · vs all stocks (USD)
5-Year Average Dividend Yield
1.70%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
-86.54MCNYFY2025 · Dec 31, 2025Revenue
669.64MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
365.19MCNYFY2025 · Dec 31, 2025Gross Profit
304.45MCNYFY2025 · Dec 31, 2025Operating Income
-136.39MCNY-20.35M · vs all stocks (USD)
Pre-tax Income
-169.32MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.96MCNYFY2025 · Dec 31, 2025Net Income
-182.28MCNYFY2025 · Dec 31, 2025EBIT
-166.14MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
50.15MCNYFY2025 · Dec 31, 2025Research & Development
62.39MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
172.91MCNYFY2025 · Dec 31, 2025Other Operating Expenses
11.75MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
18.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.18MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2100CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
623.54MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
623.54MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-182.28MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
51.34MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
185.38MCNYFY2025 · Dec 31, 2025Free Cash Flow
94.62MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
707.97MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-182.28MCNYFY2025 · Dec 31, 2025Other Non-cash Items
21.01MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
337.93MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
8.72MCNYFY2025 · Dec 31, 2025Capital Expenditures
-90.76MCNYFY2025 · Dec 31, 2025Purchase of Investments
-761.24MCNYFY2025 · Dec 31, 2025Sale of Investments
747.59MCNYFY2025 · Dec 31, 2025Other Investing Activity
-38.84MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-143.25MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
46.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-45.06MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-3.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
-139.17MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-141.73MCNYFY2025 · Dec 31, 2025Shares Outstanding
646.50MSharesUpdated Sep 21, 2026Float Shares
360.86MSharesUpdated Sep 21, 2026% Held by Insiders
46.43%vs all stocks
% Held by Institutions
1.65%vs all stocks
Total Cash (MRQ)
881.71MCNY131.57M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.41CNYUpdated Sep 21, 2026Total Debt (MRQ)
86.17MCNY12.86M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0231xvs Diagnostics & Research peers
Current Ratio (MRQ)
5.39xvs Diagnostics & Research peers
Book Value per Share (MRQ)
6.07CNYUpdated Sep 21, 2026Total Assets
4.15BCNY618.91M · vs all stocks (USD)
Total Current Assets
1.89BCNYFY2025 · Dec 31, 2025Total Liabilities
485.86MCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.25BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
133.53MCNYFY2025 · Dec 31, 2025Total Current Liabilities
352.33MCNYFY2025 · Dec 31, 2025Cash
797.20MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.36MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
798.56MCNYFY2025 · Dec 31, 2025Other Short-term Investments
240.15MCNYFY2025 · Dec 31, 2025Accounts Receivable
696.97MCNYFY2025 · Dec 31, 2025Inventory
61.86MCNYFY2025 · Dec 31, 2025Accounts Payable
86.36MCNYFY2025 · Dec 31, 2025Short-term Debt
13.09MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.12MCNYFY2025 · Dec 31, 2025Long-term Debt
76.48MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.25MCNYFY2025 · Dec 31, 2025Common Stock (Book)
646.50MCNYFY2025 · Dec 31, 2025Retained Earnings
2.33BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.66BCNY546.42M · vs all stocks (USD)
Treasury Stock
110.15MCNYFY2025 · Dec 31, 202552-Week Low
4.75CNYUpdated Sep 21, 202652-Week High
10.07CNYUpdated Sep 21, 202652-Week Change
3.87%vs all stocks
Beta
0.4260xvs all stocks
50-Day MA
5.78CNYUpdated Sep 21, 2026200-Day MA
6.07CNYUpdated Sep 21, 2026Avg 10-Day Volume
7.87MSharesUpdated Sep 21, 2026Avg 30-Day Volume
14.89MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
-0.0200CNYUpdated Sep 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.50Profit Margin: -0.02
Financial Health
Altman Z-Score 5.97: safe zoneNotable
Altman Z-Score: 5.97
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Levered free cash flow is $30.24M, above the global median of $18.73MNotable
Levered free cash flow (USD): 30,236,006.909Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Guoao Electronic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Yieh United Steel Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Insteel Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Jindao Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Integral Diagnostics Ltd
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Changzhou Almaden Stock Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Vatti Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
APAC Opto Electronics Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangzhou Jet Biofiltration Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Taiwan Sakura Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Imax China Holding, Inc.
3 interpretationsCash-Flow Ratios ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Great Eastern Shipping Company Ltd.
3 interpretationsCash-Flow Ratios ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
HPSP Co., Ltd.
3 interpretationsCash-Flow Ratios ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration